CD8A and neoplasm: Blocking of the EGFR with cetuximab when tumor cells were stimulated with the type 1 cytokine IFNγ and TNFα resulted in the amplification of the production of the T-cell attracting chemokines and resulted in an increased migration of CD4+ and CD8+ lymphocytes in chemotaxis assays in vitro.